Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system.
Alzheimer’s disease
IL-17
Parkinson’s disease
central nervous system
cytokines
depression
multiple sclerosis
neuromyelitis optica
spondyloarthritis
tumor necrosis factor alpha
uveitis
Journal
Therapeutic advances in musculoskeletal disease
ISSN: 1759-720X
Titre abrégé: Ther Adv Musculoskelet Dis
Pays: England
ID NLM: 101517322
Informations de publication
Date de publication:
2021
2021
Historique:
received:
25
02
2021
accepted:
27
05
2021
entrez:
22
7
2021
pubmed:
23
7
2021
medline:
23
7
2021
Statut:
epublish
Résumé
Tumor necrosis factor alpha (TNF-α) and interleukin-17 (IL-17) are two pro-inflammatory cytokines involved in the pathophysiology of spondyloarthritis (SpA). Therapies targeting TNF-α or IL-17 are used as a second line among SpA patients failing non-steroidal anti-inflammatory drugs. The choice of such treatment has to take into account the patient's comorbidities. Neurologic diseases are common and their association with SpA deserves to be studied. Therefore, the role of TNF-α and IL-17 cytokines is worth investigating in these neuropsychiatric diseases. This review aimed to explore the role of TNF-α and IL-17 in the pathogenesis of uveitis, multiple sclerosis, neuromyelitis optica, Alzheimer's disease, Parkinson's disease and depression. This update is critical to guide the therapeutic management of these co-morbidities in SpA patients.
Identifiants
pubmed: 34290832
doi: 10.1177/1759720X211025894
pii: 10.1177_1759720X211025894
pmc: PMC8273400
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1759720X211025894Informations de copyright
© The Author(s), 2021.
Déclaration de conflit d'intérêts
Conflict of interest statement: E. How Shing Koy has received honoraria from Novartis; P. Labauge has no disclosures; A. Baillet has received consultancy fees, and/or honoraria from Abbvie, Novartis, Medac, Pfizer, Galapagos, UCB; C. Prati has received consultancy fees, and/or honoraria, and/or grants from Novartis, Lilly, Abbvie, UCB, Fresenius; H. Marotte has received consultancy fees, and/or honoraria from Abbvie, Biogen, BMS, Lilly, MSD, Nordic Pharma, Novartis, Pfizer, Sanofi, UCB; Y-M. Pers has received consultancy fees, and/or honoraria from Novartis, Pfizer.
Références
Lancet. 2016 Sep 17;388(10050):1183-92
pubmed: 27542302
Arch Med Res. 2015 Jan;46(1):24-30.e1
pubmed: 25735998
Acta Neurol Belg. 2011 Dec;111(4):340-3
pubmed: 22368978
Pain Res Treat. 2012;2012:584573
pubmed: 22191024
Dermatol Ther. 2017 Sep;30(5):
pubmed: 28833973
JAMA Psychiatry. 2013 Jan;70(1):31-41
pubmed: 22945416
Ann Rheum Dis. 2016 Apr;75(4):785-6
pubmed: 26698850
Int J Physiol Pathophysiol Pharmacol. 2019 Dec 15;11(6):267-273
pubmed: 31993101
J Med Econ. 2012;15(6):1054-63
pubmed: 22563743
Neurobiol Aging. 2007 Apr;28(4):533-6
pubmed: 16569464
J Immunol. 2009 Mar 1;182(5):3183-90
pubmed: 19234216
Nat Med. 2007 Jun;13(6):711-8
pubmed: 17496900
J Alzheimers Dis. 2014;38(3):633-46
pubmed: 24047617
Cytokine. 2017 Sep;97:14-24
pubmed: 28570931
Brain Behav Immun. 2018 Mar;69:28-34
pubmed: 28779999
Curr Med Res Opin. 2014 Dec;30(12):2515-21
pubmed: 25252590
Microbiol Immunol. 2009 May;53(5):281-6
pubmed: 19457169
Curr Alzheimer Res. 2017;14(4):412-425
pubmed: 27697064
Ann Rheum Dis. 2016 Jun;75(6):1016-23
pubmed: 26489703
Arch Neurol. 2012 Oct;69(10):1318-25
pubmed: 22801742
Rheumatol Int. 2014 Aug;34(8):1103-10
pubmed: 24509896
Mediators Inflamm. 2017;2017:3908061
pubmed: 28316374
Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):857-72
pubmed: 25193010
Clin Exp Rheumatol. 2011 Jul-Aug;29(4):672-80
pubmed: 21906431
Neuropsychiatr Dis Treat. 2017 Oct 20;13:2661-2668
pubmed: 29118582
Int J Geriatr Psychiatry. 2018 May;33(5):688-694
pubmed: 29516540
Nat Rev Neurosci. 2009 Mar;10(3):199-210
pubmed: 19209176
Expert Opin Ther Targets. 2019 Apr;23(4):295-307
pubmed: 30856027
Brain Behav Immun. 2017 Nov;66:103-110
pubmed: 28698115
J Alzheimers Dis. 2014;38(2):403-13
pubmed: 23979026
PLoS One. 2019 Jan 31;14(1):e0210335
pubmed: 30703142
Neurosci Lett. 1994 Jan 3;165(1-2):208-10
pubmed: 8015728
Neurology. 2013 Nov 26;81(22):1945-52
pubmed: 24174584
Brain Behav Immun. 2011 Mar;25(3):539-47
pubmed: 21167930
J Neurosci. 2013 Jun 5;33(23):9592-600
pubmed: 23739956
Neurology. 1999 Aug 11;53(3):457-65
pubmed: 10449104
Ann Rheum Dis. 2020 Feb;79(2):202-208
pubmed: 31662321
J Immunol. 2010 Mar 1;184(5):2261-71
pubmed: 20118279
Cochrane Database Syst Rev. 2017 Apr 25;4:CD003200
pubmed: 28444695
Mult Scler Relat Disord. 2018 Nov;26:37-39
pubmed: 30219743
Fortschr Neurol Psychiatr. 2009 Jun;77(6):334-45
pubmed: 19415585
Int Immunopharmacol. 2019 Oct;75:105793
pubmed: 31401379
N Engl J Med. 2013 Feb 21;368(8):770-1
pubmed: 23425171
Clin Immunol. 2011 May;139(2):177-84
pubmed: 21334264
Rheumatology (Oxford). 2017 Sep 1;56(9):1498-1509
pubmed: 28498975
Mol Neurobiol. 2014 Oct;50(2):534-44
pubmed: 24567119
Br J Ophthalmol. 2015 Feb;99(2):205-9
pubmed: 25170065
Rheumatol Int. 2011 Jun;31(6):795-800
pubmed: 20221605
Curr Rheumatol Rep. 2015 Sep;17(9):59
pubmed: 26233598
Clin Neurol Neurosurg. 2018 Mar;166:76-79
pubmed: 29408778
Mol Neurobiol. 2017 Dec;54(10):7762-7776
pubmed: 27844285
Neurol Res. 2018 Mar;40(3):153-159
pubmed: 29297273
Ann Rheum Dis. 2017 Sep;76(9):1515-1521
pubmed: 28254789
Neurobiol Aging. 2001 Nov-Dec;22(6):873-83
pubmed: 11754994
J Neuroimmune Pharmacol. 2012 Mar;7(1):42-59
pubmed: 21728035
Curr Neuropharmacol. 2008 Sep;6(3):193-202
pubmed: 19506720
J Neurol. 2016 Jul;263(7):1287-95
pubmed: 27142710
Arthritis Res Ther. 2018 Jul 11;20(1):140
pubmed: 29996916
Nutrition. 2016 Feb;32(2):174-8
pubmed: 26706021
Arthritis Res Ther. 2012 Jan 23;14(1):R18
pubmed: 22269151
Rheumatology (Oxford). 2020 Oct 1;59(Suppl4):iv47-iv57
pubmed: 33053193
Ther Adv Neurol Disord. 2020 Jan 2;13:1756286419895155
pubmed: 31921355
Ann Rheum Dis. 2008 Jun;67(6):901-3
pubmed: 18474665
Curr Pharm Des. 2016;22(5):541-8
pubmed: 26601965
J Neuroimmunol. 2014 Jun 15;271(1-2):43-8
pubmed: 24703098
Ophthalmology. 2016 Aug;123(8):1632-1636
pubmed: 27084561
Acta Neuropathol. 2015 May;129(5):625-37
pubmed: 25716179
JAMA Neurol. 2018 Aug 1;75(8):939-946
pubmed: 29710331
Clin Exp Rheumatol. 2013 Nov-Dec;31(6 Suppl 79):S60-3
pubmed: 24021410
Curr Neurol Neurosci Rep. 2017 Apr;17(4):36
pubmed: 28337644
Indian J Dermatol. 2016 Mar-Apr;61(2):152-6
pubmed: 27057013
Neurosci Lett. 2017 Sep 29;658:133-136
pubmed: 28844731
J Leukoc Biol. 2017 Oct;102(4):1093-1102
pubmed: 28751472
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4251-9
pubmed: 16249505
PLoS One. 2014 Feb 28;9(2):e90117
pubmed: 24587232
Rheumatol Int. 2012 Feb;32(2):323-30
pubmed: 21079965
Dement Geriatr Cogn Disord. 2014;38(5-6):321-9
pubmed: 25138786
J Clin Neurosci. 2017 Oct;44:230-233
pubmed: 28684154
Rev Bras Reumatol. 2010 Nov-Dec;50(6):646-50
pubmed: 21243305
J Immunol. 2013 Mar 1;190(5):2241-51
pubmed: 23365075
Int J Neurosci. 2016 Dec;126(12):1051-60
pubmed: 26954363
Clin Exp Rheumatol. 2019 Nov-Dec;37(6):1096
pubmed: 31287406
Ann Rheum Dis. 1989 Dec;48(12):971-2
pubmed: 2619356
Int Ophthalmol Clin. 2000 Spring;40(2):1-18
pubmed: 10791254
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
PLoS One. 2015 Feb 06;10(2):e0116549
pubmed: 25658940
Am J Med Sci. 2018 Dec;356(6):552-560
pubmed: 30447707
Neurobiol Aging. 2014 Jan;35(1):109-21
pubmed: 23993702
Rheumatol Int. 2014 Sep;34(9):1275-80
pubmed: 24589726
Exp Gerontol. 2002 Jan-Mar;37(2-3):257-63
pubmed: 11772511
Neurology. 2010 Dec 7;75(23):2079-86
pubmed: 21048198
J Immunol. 2009 Sep 1;183(5):3522-30
pubmed: 19675171
Curr Drug Targets. 2016;17(16):1882-1893
pubmed: 26953244
Sci Rep. 2017 Jan 16;7:40414
pubmed: 28091550
Lancet. 2001 Nov 24;358(9295):1784
pubmed: 11734240
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
PLoS One. 2013 Oct 04;8(10):e75786
pubmed: 24124514
Immunol Res. 2006;34(3):229-42
pubmed: 16891673
Ocul Immunol Inflamm. 2011 Apr;19(2):108-14
pubmed: 21428748
Eur J Intern Med. 2011 Dec;22(6):554-60
pubmed: 22075279
Eur Neurol. 2008;59(1-2):91-3
pubmed: 17934280
J Inflamm (Lond). 2009 Jun 02;6:18
pubmed: 19490629
Arthritis Res Ther. 2010;12(3):R79
pubmed: 20459730
Oncotarget. 2016 Apr 26;7(17):22988-3005
pubmed: 27049828
PLoS One. 2017 Oct 19;12(10):e0186700
pubmed: 29049348
Biol Psychiatry. 2009 Jul 15;66(2):191-5
pubmed: 19185287
Ophthalmology. 2013 Apr;120(4):777-87
pubmed: 23290985
Open Access Rheumatol. 2018 Aug 17;10:113-115
pubmed: 30147384
Life Sci. 2017 Feb 15;171:16-20
pubmed: 28087373
J Neuroinflammation. 2018 Jul 12;15(1):205
pubmed: 30001736
Front Neurol. 2019 Jan 24;10:13
pubmed: 30733703
Ann Neurol. 2016 May;79(5):775-783
pubmed: 26891082
J Ophthalmol. 2013;2013:928264
pubmed: 24455197
Ophthalmology. 2004 Apr;111(4):802-9
pubmed: 15051216
Int Ophthalmol. 1990 Oct;14(5-6):303-8
pubmed: 2249907
Neurology. 2015 May 26;84(21):2161-8
pubmed: 25934853
Clin Rheumatol. 2011 Feb;30(2):269-73
pubmed: 21161669
Acta Pharmacol Sin. 2001 Jul;22(7):577-87
pubmed: 11749820
Brain Pathol. 2017 Jan;27(1):3-12
pubmed: 26667592
Clin Vaccine Immunol. 2015 Jan;22(1):72-8
pubmed: 25378353
Cutis. 2019 Dec;104(6):361-365
pubmed: 31939925
N Engl J Med. 2016 Sep 8;375(10):932-43
pubmed: 27602665
Arthritis Care Res (Hoboken). 2012 Jun;64(6):919-24
pubmed: 22262475
Age Ageing. 2016 Mar;45(2):228-35
pubmed: 26795974
Nat Med. 2012 Dec;18(12):1812-9
pubmed: 23178247
Rheumatology (Oxford). 2018 Sep 1;57(9):1541-1547
pubmed: 28968885
Neurol Res. 2016 Feb;38(2):98-102
pubmed: 27078697
Front Immunol. 2018 Apr 30;9:925
pubmed: 29760711
J Exp Med. 2008 Apr 14;205(4):799-810
pubmed: 18391061
J Clin Endocrinol Metab. 2004 Sep;89(9):4409-13
pubmed: 15356039
J Immunol. 2009 Jul 15;183(2):865-73
pubmed: 19542376
Am J Pathol. 2011 Oct;179(4):2053-70
pubmed: 21835156
Mult Scler Relat Disord. 2019 Oct;35:193-195
pubmed: 31398658
Eur Psychiatry. 2008 Sep;23(6):421-9
pubmed: 18504118
Br J Dermatol. 2018 Feb;178(2):e105-e107
pubmed: 28991372
Nat Rev Immunol. 2019 Nov;19(11):702-715
pubmed: 31289370
Neurosci Lett. 1991 Aug 19;129(2):318-20
pubmed: 1745413
J Crohns Colitis. 2020 May 21;14(4):571
pubmed: 31606743
J Neuroinflammation. 2008 May 29;5:23
pubmed: 18510752
Neurosci Lett. 2013 Oct 11;553:63-7
pubmed: 23973333
Mediators Inflamm. 2018 Apr 18;2018:3985154
pubmed: 29849487
Ophthalmology. 2015 May;122(5):939-48
pubmed: 25638011
Sci Transl Med. 2010 Oct 6;2(52):52ra72
pubmed: 20926833
Eur J Dermatol. 2016 Oct 1;26(5):506-507
pubmed: 27789419
Rheumatol Int. 2013 Apr;33(4):1039-45
pubmed: 22940709
Cell Stem Cell. 2018 Jul 05;23(1):123-131.e6
pubmed: 29979986
Rheumatology (Oxford). 2013 May;52(5):868-74
pubmed: 23287362
Sci Rep. 2018 Aug 13;8(1):12050
pubmed: 30104698